SonoSite Appoints Brian Noyes, 20 Year Veteran of Johnson & Johnson, Vice President of Marketing
November 15 2011 - 2:50PM
Business Wire
SonoSite, Inc. (Nasdaq:SONO), the world leader and
specialist in bedside and point-of-care ultrasound, today announced
the appointment of Brian Noyes as the Vice President of Marking for
North America and South America.
“Brian is an excellent addition to SonoSite and we welcome him
to the leadership team,” said Matthew Damron, SonoSite’s Global
Chief Marketing Officer. “He is an accomplished leader with decades
of experience in the medical device industry, a successful product
launch track record, and a key factor in the growth of a $1 billion
franchise at Johnson & Johnson. Brian is a very appealing
candidate to further elevate our marketing execution to the next
level with expertise that is essential as we prepare to unleash the
most exciting products in our company’s history.”
“SonoSite is a company with tremendous growth opportunities and
has an enviable position in the healthcare industry,” said Brian
Noyes. “I’m joining the company at a very exciting time, and I look
forward to capitalizing on the current marketing initiatives,
driving product demand, and market expansion.”
Brian Noyes is an experienced leader in the healthcare industry
and for the last 20 years, he worked at Ethicon Endo-Surgery (EES),
a Johnson & Johnson Company, which is a leader in energy-based
surgical devices. Holding positions of increasing responsibility,
Mr. Noyes most recently served as the Global Product Director of
the Energy Franchise where he was responsible for the development
and marketing of a $1 billion franchise for laparoscopic products.
In this role, Mr. Noyes was also responsible for launching products
internationally and leading cross-functional teams. Previous to
this position, he held managerial positions in sales and marketing.
Prior to joining EES, Mr. Noyes worked at Camadon, Inc. in sales
and marketing.
Mr. Noyes will report directly to Matthew Damron.
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world
leader in bedside and point-of-care ultrasound and an industry
leader in ultra high-frequency micro-ultrasound technology and
impedance cardiography equipment. Headquartered near Seattle, the
company is represented by ten subsidiaries and a global
distribution network in over 100 countries. SonoSite’s small,
lightweight systems are expanding the use of ultrasound across the
clinical spectrum by cost-effectively bringing high-performance
ultrasound to the point of patient care.
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2023 to Jul 2024